Literature DB >> 9189892

Marked decrease of immunolabelled 68 kDa neurofilament (NF-L) proteins in brains of opiate addicts.

J A García-Sevilla1, P Ventayol, X Busquets, R La Harpe, C Walzer, J Guimón.   

Abstract

NEUROFILAMENT (NF) proteins, the major components of the neuronal cytoskeleton, have been shown to represent previously unknown targets for the chronic effects of morphine in rats. This study was designed to evaluate the abundance of immunoreactive NF-L (68 kDa) proteins in post-mortem brains of chronic opiate addicts who had died of a heroin or methadone overdose. Levels of NF-L proteins were assessed by immunoblotting techniques. Levels of immunoreactive NF-L proteins were markedly decreased (47%, n = 17) in the frontal cortex. The reduced abundance of brain NF-L proteins was not related to the post-mortem delay or to the plasma concentrations of opiates, suggesting that the observed changes represent a specific long-term effect of opiate drugs. Because of the functions associated with NF proteins (e.g. axonal transport), this finding suggests that opiate drugs may induce neuronal damage after chronic abuse in humans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9189892     DOI: 10.1097/00001756-199705060-00003

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

1.  Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse.

Authors:  E Lehrmann; J Oyler; M P Vawter; T M Hyde; B Kolachana; J E Kleinman; M A Huestis; K G Becker; W J Freed
Journal:  Pharmacogenomics J       Date:  2003       Impact factor: 3.550

2.  Parallel modulation of receptor for activated C kinase 1 and protein kinase C-alpha and beta isoforms in brains of morphine-treated rats.

Authors:  P V Escribá; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

3.  Altered prefrontal and insular cortical thickness in adolescent marijuana users.

Authors:  Melissa P Lopez-Larson; Piotr Bogorodzki; Jadwiga Rogowska; Erin McGlade; Jace B King; Janine Terry; Deborah Yurgelun-Todd
Journal:  Behav Brain Res       Date:  2011-02-12       Impact factor: 3.332

4.  Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain.

Authors:  M A Boronat; M J García-Fuster; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

Review 5.  Neuropathology of substance use disorders.

Authors:  Jean Lud Cadet; Veronica Bisagno; Christopher Mark Milroy
Journal:  Acta Neuropathol       Date:  2013-11-29       Impact factor: 17.088

Review 6.  Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders.

Authors:  Aidong Yuan; Ralph A Nixon
Journal:  Brain Res Bull       Date:  2016-09-05       Impact factor: 4.077

7.  Cortico-cerebellar abnormalities in adolescents with heavy marijuana use.

Authors:  Melissa P Lopez-Larson; Jadwiga Rogowska; Piotr Bogorodzki; Charles Elliott Bueler; Erin C McGlade; Deborah A Yurgelun-Todd
Journal:  Psychiatry Res       Date:  2012-07-24       Impact factor: 3.222

8.  Modulation of Fas receptor proteins and dynamin during opiate addiction and induction of opiate withdrawal in rat brain.

Authors:  M Julia García-Fuster; Marcel Ferrer-Alcón; Antonio Miralles; Jesús A García-Sevilla
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-03       Impact factor: 3.000

9.  Neurofilament subunits are integral components of synapses and modulate neurotransmission and behavior in vivo.

Authors:  A Yuan; H Sershen; B S Basavarajappa; A Kumar; A Hashim; M Berg; J-H Lee; Y Sato; M V Rao; P S Mohan; V Dyakin; J-P Julien; V M-Y Lee; R A Nixon
Journal:  Mol Psychiatry       Date:  2015-04-14       Impact factor: 15.992

10.  Neuropathological alterations in drug abusers : The involvement of neurons, glial, and vascular systems.

Authors:  Andreas Büttner; Serge Weis
Journal:  Forensic Sci Med Pathol       Date:  2006-06       Impact factor: 2.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.